| scholarly article | Q13442814 |
| P2093 | author name string | Fozya Bashal | |
| P2860 | cites work | Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus | Q37158591 |
| A systematic review of the off-label use of biological therapies in systemic autoimmune diseases | Q37326300 | ||
| A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus | Q37378350 | ||
| Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale? | Q37547996 | ||
| The interplay between the antiphospholipid syndrome and systemic lupus erythematosus | Q37610418 | ||
| Potential role of IFNα in adult lupus | Q37730992 | ||
| An open study of B lymphocyte depletion in systemic lupus erythematosus | Q44183280 | ||
| TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus | Q44786845 | ||
| T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil | Q45245313 | ||
| Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. | Q50196335 | ||
| Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. | Q51752520 | ||
| The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. | Q51766317 | ||
| The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. | Q54791103 | ||
| Management of antiphospholipid syndrome | Q57656275 | ||
| Letter to the Editor | Q58621758 | ||
| Autoimmune thrombocytopenic purpura | Q68943939 | ||
| Splenectomy and the thrombocytopenia of systemic lupus erythematosus | Q69656381 | ||
| Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus | Q73782509 | ||
| Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia | Q79324678 | ||
| Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation | Q81712990 | ||
| Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome | Q84302617 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
| A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response | Q33330951 | ||
| Azathioprine therapy for patients with systemic lupus erythematosus | Q33336950 | ||
| The treatment of lupus with cyclosporin A. | Q33336953 | ||
| Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases | Q33340868 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus | Q33361803 | ||
| Lupus thrombocytopenia: clinical implications and prognostic significance | Q33367827 | ||
| Moderate and severe neutropenia in patients with systemic lupus erythematosus | Q33370282 | ||
| Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus | Q33370573 | ||
| The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias | Q33374191 | ||
| Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13. | Q33375737 | ||
| Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus | Q33380794 | ||
| A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus | Q33383190 | ||
| Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus | Q33384656 | ||
| Use of rituximab in the antiphospholipid syndrome | Q33389337 | ||
| The management of peripheral blood cytopenias in systemic lupus erythematosus | Q33391779 | ||
| Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia | Q33392577 | ||
| Systemic lupus erythematosus presenting as thrombotic thrombocytopenia purpura: how close is close enough? | Q33395602 | ||
| The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab | Q33396033 | ||
| Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus | Q33404430 | ||
| Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus | Q33405430 | ||
| Evaluation of azathioprine in autoimmune thrombocytopenia and lupus erythematosus. | Q33466144 | ||
| Pulse methylprednisolone in SLE. | Q33481236 | ||
| Pulse corticosteroid therapy for refractory thrombocytopenia in systemic lupus erythematosus | Q33484505 | ||
| Haematological manifestations of systemic lupus erythematosus. | Q33492384 | ||
| Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study | Q33496027 | ||
| Danazol for thrombocytopenia in pregnancy with underlying systemic lupus erythematosus. | Q33496305 | ||
| Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans' syndrome | Q33498179 | ||
| Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin | Q35549199 | ||
| Mechanisms of action of mycophenolate mofetil | Q36085841 | ||
| Update on antiphospholipid syndrome | Q36661158 | ||
| Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers | Q36843689 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 87-95 | |
| P577 | publication date | 2013-10-18 | |
| P1433 | published in | The open rheumatology journal | Q27722052 |
| P1476 | title | Hematological disorders in patients with systemic lupus erythematosus | |
| P478 | volume | 7 |
| Q33423646 | Autoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signaling |
| Q93108653 | Does the Epstein-Barr Virus Play a Role in the Pathogenesis of Graves' Disease? |
| Q41670053 | HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus |
| Q58603868 | Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco |
| Q26822662 | Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus |
| Q41050286 | Oxidized Hemoglobin Is Antigenic and Immunogenic in Lupus |
| Q46373068 | Phagocyte activity in the peripheral blood of pregnant women with systemic lupus erythematosus and in the cord blood of their newborns |
| Q33436120 | Polymorphisms in NAT2 (N-acetyltransferase 2) gene in patients with systemic lupus erythematosus |
| Q47952608 | Relationship between prevalence and severity of restless legs syndrome and anemia in patients with systemic lupus erythematosus |
| Q33414666 | Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag |
| Q30251813 | Systemic lupus erythematosus in Nepal: A review. |
| Q41487980 | The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach |
| Q55129731 | The Role of Hydroxychloroquine as a Steroid-sparing Agent in the Treatment of Immune Thrombocytopenia: A Review of the Literature. |
| Q89128410 | Zytopenien : Anämie, Leukopenie und Thrombopenie |
Search more.